K023269 is an FDA 510(k) clearance for the HEMOSIL C-REACTIVE PROTEIN - HIGH SENSITIVITY AND HIGH SENSITIVITY CONTROLS. This device is classified as a C-reactive Protein, Antigen, Antiserum, And Control (Class II - Special Controls, product code DCK).
Submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on December 23, 2002, 83 days after receiving the submission on October 1, 2002.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 866.5270.